IngentaConnect Serum and Plasma Vascular Endothelial Growth Factor Levels in Var...

Abstract:

Introduction:

Vascular endothelial growth factor (VEGF) is one of the most important mediators of angiogenesis. Elevated levels within tumors, and in serum, plasma, and tumor effusion have been correlated with the development of metastatic disease, recurrence, and poor prognosis in many tumors in humans. Canine VEGF has been sequenced as homologous with the human form, and elevated serum and plasma VEGF have been found in dogs with hemangiosarcoma. Feline VEGF has also been sequenced, and shares homology with the human and canine forms. Materials and Methods:

Stored serum and plasma samples from normal cats, cats with various neoplasms, and cats with non-neoplastic disease were evaluated with a commercial ELISA kit (R&D Systems, Minneapolis MN). Samples were run in duplicate, and a standard curve was performed for each plate. The data were analyzed for differences between populations, and between serum and plasma levels in the same patient to determine the optimal sample for evaluating VEGF in cats. Results:

In seven apparently healthy cats mean plasma VEGF was 95.6 pg/mL. In non-neoplastic disease (7 cases), mean plasma VEGF was 117.3 pg/mL and mean serum VEGF level was 219.7 pg/mL. In ten tumor-bearing patients mean plasma VEGF was 247.1 pg/mL, and mean serum VEGF was 322.3 pg/mL. Statistical analysis showed no significant difference between mean serum and plasma VEGF concentrations within each group or between groups (p > 0.05). Discussion:

Serum and plasma VEGF levels could not be used to distinguish between healthy cats and cats with neoplastic or non-neoplastic disease.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.16 plus tax Refund Policy

Serum and Plasma Vascular Endothelial Growth Factor Levels in Various Cat Populations